Drug Markets/Norethindrone

Norethindrone

25 NDCs across 12 manufacturers|25 Generic,0 Brand

Norethindrone is used to treat acne vulgaris, endometrial hyperplasia, endometriosis, hypogonadism and menorrhagia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Oct 21, 2002. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Norethindrone across 81,000 claims for 25,000 beneficiaries.

Norethindrone is available as 25 NDCs from 12 manufacturers (25 generic, 0 brand), with NADAC prices from $0.09 to $0.29 per EA — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

25

25G / 0B

Manufacturers

12

competing in market

Price Spread

$0.09 – $0.29

per EA

7d Activity

18↑2↓5 flat

avg +1.6% WoW · of 25 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

25 NDCs total, 25 shown

Drug ↕Price 7d Change ↕
NORETHINDRONE 5 MG TABLET
$0.2898
per EA
-1.70%
NORETHINDRONE 5 MG TABLET
$0.2898
per EA
-1.70%
NORA-BE TABLET
$0.0943
per EA
—
SHAROBEL 0.35 MG TABLET
$0.0924
per EA
+1.96%
SHAROBEL 0.35 MG TABLET
$0.0924
per EA
+1.96%
LYLEQ 0.35 MG TABLET
$0.0924
per EA
+1.96%
EMZAHH 0.35 MG TABLET
$0.0924
per EA
+1.96%
EMZAHH 0.35 MG TABLET
$0.0924
per EA
+1.96%
INCASSIA 0.35 MG TABLET
$0.0924
per EA
+1.96%
INCASSIA 0.35 MG TABLET
$0.0924
per EA
+1.96%
NORA-BE TABLET
$0.0924
per EA
+1.96%
JENCYCLA 0.35 MG TABLET
$0.0924
per EA
+1.96%
HEATHER 0.35 MG TABLET
$0.0924
per EA
+1.96%
NORETHINDRONE 0.35 MG TABLET
$0.0924
per EA
+1.96%
ORQUIDEA 0.35 MG TABLET
$0.0924
per EA
+1.96%
MELEYA 0.35 MG TABLET
$0.0924
per EA
+1.96%
CAMILA 0.35 MG TABLET
$0.0924
per EA
+1.96%
ERRIN 0.35 MG TABLET
$0.0924
per EA
+1.96%
NORETHINDRONE 0.35 MG TABLET
$0.0924
per EA
+1.96%
DEBLITANE 0.35 MG TABLET
$0.0924
per EA
+1.96%
DEBLITANE 0.35 MG TABLET
$0.0924
per EA
+1.96%
ERRIN 0.35 MG TABLET
$0.0906
per EA
—
NORETHINDRONE 0.35 MG TABLET
$0.0906
per EA
—
NORETHINDRONE 0.35 MG TABLET
$0.0906
per EA
—
CAMILA 0.35 MG TABLET
$0.0906
per EA
—

Frequently Asked Questions

What is Norethindrone used to treat?

Norethindrone is used to treat acne vulgaris, endometrial hyperplasia, endometriosis, hypogonadism and menorrhagia, per the National Library of Medicine's MED-RT classification.

When did Norethindrone become available as a generic?

FDA approved the first generic Norethindrone (ANDA) on Oct 21, 2002. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Norethindrone?

In 2024, Medicare Part D spent $2 million on Norethindrone across 81,000 claims for 25,000 beneficiaries.

How many Norethindrone products are on the market?

The Norethindrone drug market contains 25 NDCs from 12 manufacturers — 25 generic and 0 brand products.

What is the price range for Norethindrone?

NADAC reference prices for Norethindrone range from $0.0906 to $0.2898 per EA — the most expensive product costs about 3.2× the cheapest.

Which manufacturers make Norethindrone?

12 manufacturers list Norethindrone in NADAC. Ranked by number of NDCs, the largest are NorthStar Rx LLC (4), Aurobindo Pharma Limited (4), Amneal Pharmaceuticals LLC (2), Lupin Pharmaceuticals Inc. (2), Glenmark Pharmaceuticals Inc., USA (2).

How has the price of Norethindrone changed recently?

Over the past 7 days, 18 Norethindrone NDCs rose and 2 fell, with a market-wide average change of +1.6%.